Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - Cyclacel Pharmaceuticals, Inc. | cycc-20200331ex3128a597b.htm |
| EX-32.1 - EX-32.1 - Cyclacel Pharmaceuticals, Inc. | cycc-20200331ex321926fb2.htm |
| EX-31.1 - EX-31.1 - Cyclacel Pharmaceuticals, Inc. | cycc-20200331ex31128a1ca.htm |
| 10-Q - 10-Q - Cyclacel Pharmaceuticals, Inc. | cycc-20200331x10q.htm |
EXHIBIT 32.2
Certification of Principal Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. s 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Cyclacel Pharmaceuticals, Inc. ( the “Company”) hereby certifies, to such officer’s knowledge, that:
|
(i) |
the Quarterly Report on Form10-Q of the Company for the three months ended March 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
|
(ii) |
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: May 12, 2020 |
/s/ Paul McBarron |
|
|
Paul McBarron |
|
|
Chief Operating Officer, Chief Financial Officer |
|
|
and Executive Vice President, Finance |